ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells

Nat Commun. 2023 Dec 20;14(1):8463. doi: 10.1038/s41467-023-44319-3.

Abstract

Brain endothelial LDL receptor-related protein 1 (LRP1) is involved in the clearance of Aβ peptides across the blood-brain barrier (BBB). Here we show that endothelial deficiency of ankyrin repeat and SAM domain containing 1 A (ANKS1A) reduces both the cell surface levels of LRP1 and the Aβ clearance across the BBB. Association of ANKS1A with the NPXY motifs of LRP1 facilitates the transport of LRP1 from the endoplasmic reticulum toward the cell surface. ANKS1A deficiency in an Alzheimer's disease mouse model results in exacerbated Aβ pathology followed by cognitive impairments. These deficits are reversible by gene therapy with brain endothelial-specific ANKS1A. In addition, human induced pluripotent stem cell-derived BBBs (iBBBs) were generated from endothelial cells lacking ANKS1A or carrying the rs6930932 variant. Those iBBBs exhibit both reduced cell surface LRP1 and impaired Aβ clearance. Thus, our findings demonstrate that ANKS1A regulates LRP1-mediated Aβ clearance across the BBB.

MeSH terms

  • Amyloid beta-Peptides / metabolism
  • Animals
  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Endothelial Cells / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Low Density Lipoprotein Receptor-Related Protein-1* / genetics
  • Low Density Lipoprotein Receptor-Related Protein-1* / metabolism
  • Mice
  • Receptors, LDL / genetics
  • Receptors, LDL / metabolism

Substances

  • Amyloid beta-Peptides
  • Low Density Lipoprotein Receptor-Related Protein-1
  • LRP1 protein, human
  • Receptors, LDL
  • ANKS1A protein, human
  • Anks1 protein, mouse
  • Lrp1 protein, mouse